MENU
+Compare
MEDIF
Stock ticker: OTC
AS OF
Aug 6 closing price
Price
$0.05
Change
-$0.00 (-0.00%)
Capitalization
19.13M

MEDIF Medipharm Labs Corporation Forecast, Technical & Fundamental Analysis

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids... Show more

MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MEDIF with price predictions
Aug 06, 2025

MEDIF's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MEDIF turned positive on July 14, 2025. Looking at past instances where MEDIF's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where MEDIF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MEDIF advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MEDIF as a result. In of 115 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEDIF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MEDIF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.515) is normal, around the industry mean (64.082). P/E Ratio (0.000) is within average values for comparable stocks, (89.433). MEDIF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (0.895) is also within normal values, averaging (18.681).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MEDIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
151 John Street
Phone
+1 705 719-7425
Employees
130
Web
https://www.medipharmlabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECRFF0.11N/A
+0.55%
Cartier Resources, Inc.
ADBKF25.75N/A
N/A
ADDIKO BK AG
NCTKF15.81N/A
N/A
Nabtesco Corp.
SCVPY4.90N/A
N/A
Siam Cement Public Co. Ltd.
CWID1.10N/A
N/A
Country-Wide Insurance Co.

MEDIF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MEDIF has been loosely correlated with CGC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDIF jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDIF
1D Price
Change %
MEDIF100%
-1.74%
CGC - MEDIF
36%
Loosely correlated
-2.78%
TLRY - MEDIF
28%
Poorly correlated
-2.93%
ACB - MEDIF
24%
Poorly correlated
-7.93%
AAWH - MEDIF
24%
Poorly correlated
+2.15%
GLASF - MEDIF
24%
Poorly correlated
-4.00%
More